Rotigotine
Who holds supplier records for Rotigotine? 10 organisations hold a current record for Rotigotine: an active US FDA Type II Drug Master File or a CEP. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), China (2), Peru (1), Israel (1) and 2 other countries (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Rotigotine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rotigotine
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Rotigotine expires 1 Mar 2032. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Rotigotine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- INTERQUIM SAPeruCEP Company GMP cert on recordActive DMF 26481 · latest filing Sept 2012
- Neuland Laboratories LimitedIndiaCEPActive DMF 32684 · latest filing Mar 2018
- WAVELENGTH ENTERPRISES LTDIsraelCEP Company GMP cert on recordActive DMF 26236 · latest filing Jul 2012
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 27370 · latest filing Aug 2013
- Sichuan Qingmu Pharmaceutical Co., Ltd.ChinaActive DMF 38363 · latest filing May 2023
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 37811 · latest filing Dec 2022
- TAPI NL BVNetherlandsActive DMF 29468 · latest filing Jun 2015
- Chengdu EASTON Biopharmaceuticals Co., Ltd.ChinaCEP
- OLON SPAItalyCEP Company GMP cert on recordInactive DMF 25863 · latest filing Mar 2012
- IndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Rotigotine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2020-010 - Rev 05 Rotigotine, Form II | Jun 2026 | — |
| INTERQUIM S.A. Sant Cugat Del Valles | ES | CEP 2019-302 - Rev 03 Rotigotine | Apr 2026 | Inspected Sept 2024 Spain |
| OLON S.P.A. Rodano | IT | CEP 2022-040 - Rev 01 Rotigotine, Polymorph II | Jul 2025 | Inspected Mar 2025 Italy |
| SHODHANA LABORATORIES PRIVATE LIMITED Hyderabad | IN | CEP 2024-265 - Rev 00 Rotigotine | Jul 2025 | — |
| WAVELENGTH ENTERPRISES LTD. Petah Tikva | IL | CEP 2021-291 - Rev 02 Rotigotine | Oct 2024 | — |
| CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD. Chengdu | CN | R0-CEP 2022-035 - Rev 00 Rotigotine | Aug 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (6 listed products contain Rotigotine). The latest listed patent expires 1 Mar 2032. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Rotigotine is a non-ergoline, dopamine agonist used in the treatment of Parkinson’s disease and restless legs syndrome. It functions as a transdermal patch to deliver continuous stimulation to dopamine receptors.
Chemical identity
- IUPAC name
- (6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol
- Canonical SMILES
- CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O
- InChIKey
- KFQYTPMOWPVWEJ-INIZCTEOSA-N
- Synonyms
- Neupro API, leganto, neupro, spm 962, spm-962
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nonergot Dopamine Agonist
- Mechanism of action
- Dopamine Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Rotigotine?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Rotigotine: INTERQUIM SA (Peru), Neuland Laboratories Limited (India), WAVELENGTH ENTERPRISES LTD (Israel), MATRIX PHARMACORP PRIVATE LTD (India), Sichuan Qingmu Pharmaceutical Co., Ltd. (China), SOLARA ACTIVE PHARMA SCIENCES LTD (India), TAPI NL BV (Netherlands) and Chengdu EASTON Biopharmaceuticals Co., Ltd. (China), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Rotigotine Drug Master Files are active?
INTERQUIM SA (DMF 26481), Neuland Laboratories Limited (DMF 32684), WAVELENGTH ENTERPRISES LTD (DMF 26236), MATRIX PHARMACORP PRIVATE LTD (DMF 27370), Sichuan Qingmu Pharmaceutical Co., Ltd. (DMF 38363), SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 37811) and TAPI NL BV (DMF 29468). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Rotigotine have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Rotigotine on the EDQM register, including NEULAND LABORATORIES LIMITED Hyderabad (IN), INTERQUIM S.A. Sant Cugat Del Valles (ES), OLON S.P.A. Rodano (IT), SHODHANA LABORATORIES PRIVATE LIMITED Hyderabad (IN), WAVELENGTH ENTERPRISES LTD. Petah Tikva (IL) and CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD. Chengdu (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Rotigotine?
Yes. The latest patent listed for an approved US product containing Rotigotine expires 1 Mar 2032, across 6 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Rotigotine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Rotigotine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.